Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Product Launch
Cue Health launches at-home diagnostic tests, expands test-to-treat service
March 13, 2023
Cardio Diagnostics launches AI-based blood test for the early detection of coronary heart disease
PrecisionCHD is an integrated epigenetic-genetic blood test that uses machine learning for the early detection of coronary heart disease.
February 28, 2023
Thermo Fisher introduces TaqMan qPCR master mixes
The TaqMan Lyo-Ready Master Mixes are optimized for consistent performance prior to and following lyophilization and include guidelines to support molecular diagnostic kit manufacturers.
February 24, 2023
Curio Bioscience emerges from stealth mode with whole-transcriptome spatial mapping kit
Its spatial mapping Curio Seeker kit enables life science researchers to access high-resolution transcriptomics information in their organism of choice, the firm said.
February 8, 2023
Exact Sciences launches NGS test for cancer therapy selection
The genomic test identifies tumor DNA and RNA alterations to generate a molecular picture of the patient's cancer. Test results are personalized for each patient to enable precise treatment.
February 7, 2023
Roche launches COVID-19 PCR test to detect fast-spreading XBB.1.5 Omicron subvariant
XBB.1.5 is prevalent in the U.S. and is quickly spreading to other countries. It is a subvariant of a SARS-CoV-2 variant called XBB. That lineage is a recombinant of two descendants of the BA.2 lineage, which began spiking early in 2022.
January 26, 2023
Molecular diagnostic instrument vital in QuidelOrtho combination
At the 41st Annual J.P. Morgan Healthcare Conference on Monday, QuidelOrtho's CEO said the rollout of the Savannah molecular diagnostic platform was instrumental in the decision to combine the two firms.
January 10, 2023
Alercell preparing January launch of sequencing test for leukemia
The Montana-based firm also aims to launch a methylation-based molecular diagnostic test for lung cancer later in the first quarter of 2023.
December 29, 2022
Minnesota residents to get Cue Health COVID-19 testing, treatment at no cost
Minnesotans who test positive on any COVID-19 self test can consult virtually and on-demand with a healthcare professional to obtain a prescription when deemed necessary for COVID-19 treatment at no cost.
December 23, 2022
C2N Diagnostics launching next-generation blood test for Alzheimer's disease detection
With an anticipated launch in the first quarter of 2023, the PrecivityAD2 blood test would facilitate earlier diagnosis of Alzheimer's disease pathology than is possible with current tests, the firm said.
November 29, 2022
Juno Diagnostics launches noninvasive prenatal screening test
The Juno Hazel test leverages a sample collection kit to enable the immediate generation of blood plasma for testing using a few drops of blood.
November 18, 2022
AMP 2022 video: Immunexpress CEO describes rapid molecular test for sepsis
At the Association for Molecular Pathology 2022 annual meeting and exposition recently, Immunexpress showcased a rapid molecular diagnostic test that could enable ruling in or ruling out sepsis in one hour.
November 15, 2022
Page 1 of 4
Next Page
